|Systematic (IUPAC) name|
|Metabolism||Hydrolysis by plasma esterases|
|Biological half-life||40–84 seconds|
|ATC code||N01BA02 (WHO) C05 S01|
|Molar mass||236.31 g/mol[[Script error: No such module "String".]]|
Procaine is a local anesthetic drug of the amino ester group. It is used primarily to reduce the pain of intramuscular injection of penicillin, and it was also used in dentistry. Owing to the ubiquity of the trade name Novocain, procaine is usually referred to generically as novocaine. It acts mainly by being a sodium channel blocker.
Procaine was first synthesized in 1905, shortly after amylocaine, and is the oldest man-made local anesthetic still in clinical use. It was created by the German chemist Alfred Einhorn (1856–1917) who gave the chemical the trade name Novocaine, from the Latin nov- (meaning new) and -caine, a common ending for alkaloids used as anesthetics. It was introduced into medical use by surgeon Heinrich Braun (1862–1934).
Procaine is used less frequently today since more effective (and hypoallergenic) alternatives such as lidocaine (Xylocaine) exist. Prior to the discovery of procaine, cocaine was the most commonly used local anesthetic. Like other local anesthetics (with the exception of cocaine), mepivacaine, and prilocaine, procaine is a vasodilator, and is often coadministered with epinephrine for the purpose of vasoconstriction. Vasoconstriction helps to reduce bleeding and prevents the drug from reaching systemic circulation in large amounts. Also unlike cocaine, procaine does not have the euphoric and addictive qualities that put it at risk for abuse.
Procaine, an ester anesthetic, is metabolized in the plasma by the enzyme pseudocholinesterase through hydrolysis into para-amino benzoic acid (PABA), which is then excreted by the kidneys into the urine. Allergic reactions to procaine are usually not in response to procaine itself, but to PABA. About 1 in 3000 people have an atypical form of pseudocholinesterase, which does not hydrolyze ester anesthetics such as procaine, resulting in a prolonged period of high levels of the anesthetic in the blood and increased toxicity.
Procaine is the primary ingredient in the controversial preparation Gerovital H3 by Ana Aslan (Romania), which is claimed by its advocates to remedy many effects of aging. The mainstream medical view is that these claims were seriously studied and discredited in the 1960s.
Cite error: Invalid
parameter "group" is allowed only.
<references />, or
<references group="..." />
- Hahn-Godeffroy, J.D.: Wirkungen und Nebenwirkungen von Procain: was ist gesichert?. Komplement. integr. Med. 02/2007, 32-34
- DrugBank - Showing drug card for Procaine (DB00721) Update Date 2009-06-23
- Ritchie, J. Murdoch; Greene, Nicholas M. (1990). "Local Anesthetics". In Gilman, Alfred Goodman; Rall, Theodore W.; Nies, Alan S.; Taylor, Palmer. Goodman and Gilman's The Pharmacological Basis of Therapeutics (8 ed.). New York: Pergamon Press. p. 311. ISBN 0080402968.